Week six: my off week.

No chemo this week. I am getting the stitches out of the punch biopsies that Dermatology Department did two weeks ago. I get results next week.

I've been dealing with fatigue, had a quiet weekend. Now back to work.

My roommate and I discussed the outcomes of this. The chemo is because of the liver mets which seems to be a small lesion. There are four lung nodules, all smaller than 2.0 cm. The Gem/Tax is hopefully taking care of those. So the next step will be a PET scan to see if the treatment is working. When this is over I'll be monitored carefully for the rest of my life.

Current side effects include the reaction on my hands, which is responding well to Eucerin Baby Eczema Relief. They tend to throb when my blood pressure is up, so I'm forcing fluids and taking my lisinopril faithfully. I'm taking Advil to control the pain when it is too much. Three weeks ago I resorted to other pain meds, and am grateful I didn't need them this cycle.

This weekend was fatigue filled, but the Neulastin shot didn't cause bone pain... or far less pain than last cycle.

No chemo this week. I'm looking forward to pretending to be normal.

Comments

Post a Comment

Popular posts from this blog

After waiting.... more waiting

It's been a long two months since I last wrote. I've been battling fatigue and depression while waiting for a clinical trial to open.  Parts of the problem are physical, lung tumor is pressing against lung, making it harder to breathe.  I've also got a painful cough.  Nights I've been taking fever reducers, then sweating.  This past Monday, I was admitted to the hospital for a clinical trial (I'm very excited). Only the fevers prevent me from starting the trial.  So we've run tests to find if there is an infection.  No.  Virus? No. They're giving me a week's antibiotics, and Advil to keep the fever down.  Next Monday I start the study.  I'm in the hospital basically for the next 3 weeks, Monday through Friday.  (as per research protocol. I'm ready for something to happen....
Read more

Possible scenarios.... outcomes... and preparing for the future.

In the first days of this adventure, I found this TED talk. Baba Shiv talks about giving up the driver's seat TED Talk .  With this rare form of cancer, I choose to listen to my oncologist, and follow her directions.  My goal is to live another 10 years.  My roommate challenged that recently.  His sister has battled a variety of cancers for many years.  She's tenacious, intelligent and currently in remission.  Cancer has become a chronic disease for many.  I don't know.  I don't have the data (until the results are reviewed by my physician) from the latest CT with contrast scan.  I've gathered the old CT scans from other facilities and will be taking them to Moffitt next Tuesday.  Then... well, then we'll have a battle plan.  Overall, I'm working on multiple outcomes.  I need to be prepared.  For example, I'm going through my bookshelves and discarding many books.  Why?  I may be moving to a different home.  Even if I'm not moving, I need to ma
Read more

Research update. Letrezole use for 10 years post breast cancer.

Below is a link to the original article. I realize that links don't live forever, so I've copied the article. I am currently on Letrezole.... and having bone pain. --Although that is something I'll be discussing with the doctor at Friday's appointment. Remember there are no easy answers... so a way to prolong life, also has side effects... pain, and reduced bone density. I'm grateful that I've drank as much milk as I have during the past decades. Hopefully, that will help strengthen my bones during this treatment. This also shows how treatments can cross from one cancer to another. I'm not sure there are any official treatments for my cancer, it is just too rare... so we keep trying new and interesting treatments. Washington Post Article about breast cancer and Letrezole Extending anti-estrogen therapy to 10 years reduces breast-cancer recurrence, new cancers CHICAGO — Researchers said extending hormone therapy to 10 years reduces the risk
Read more